Related Experiment Video
Updated: Jun 23, 2026

Measuring Psoriasis Severity at Home
Published on: March 1, 2024
Development and initial validation of a heart disease knowledge questionnaire for people with rheumatoid arthritis
Holly John1, Gareth J Treharne, Elizabeth D Hale
1Department of Rheumatology, Dudley Group of Hospitals NHS Foundation Trust, Dudley, UK. Holly.John@dgoh.nhs.uk
Insights
Two parallel versions of the Heart Disease Fact Questionnaire-Rheumatoid Arthritis (HDFQ-RA) were developed and validated. These reliable and valid tools measure cardiovascular disease knowledge in rheumatoid arthritis patients.
Area of Science:
- Rheumatology
- Cardiovascular Health
- Psychometrics
Background:
- Rheumatoid arthritis (RA) patients face increased cardiovascular disease (CVD) risk.
- Assessing CVD knowledge in RA patients is crucial for targeted interventions.
- Existing tools may not adequately address RA-specific concerns regarding CVD.
Purpose of the Study:
- To develop and validate two parallel forms of the Heart Disease Fact Questionnaire-Rheumatoid Arthritis (HDFQ-RA).
- To create an RA-specific instrument for measuring CVD knowledge.
- To ensure the reliability and validity of the new HDFQ-RA forms.
Main Methods:
- Modified the original HDFQ with RA-specific questions.
- Utilized cognitive interviewing and piloting to create two parallel questionnaires.
- Conducted psychometric validation with 130 RA patients, including test-retest reliability and known groups comparison.
Main Results:
- Established parallel form reliability and test-retest stability for both HDFQ-RA versions (median score 9/13).
- Achieved Kuder-Richardson-20 reliability coefficients of 0.65 and 0.67.
- Demonstrated higher scores in patients who self-educated on heart disease or used CVD medications, supporting construct validity.
Conclusions:
- The two parallel HDFQ-RA forms are equivalent, reliable, and valid measures of CVD knowledge.
- The HDFQ-RA is suitable for clinical and research settings, including evaluating educational interventions and tracking participant progress.
Objective:
To develop and validate two parallel versions of the Heart Disease Fact Questionnaire-Rheumatoid Arthritis (HDFQ-RA), a modified and RA-specific version of the HDFQ.
Methods:
The questionnaire was composed of generic questions from the original HDFQ with additional RA-specific questions added. Cognitive interviewing was performed and the questionnaire piloted to generate two parallel questionnaires. For psychometric validation, 130 patients with RA completed the questionnaires at baseline and 2 weeks later.
Results:
Parallel form reliability of both questionnaires was established; the median score for both questionnaires was 9/13 with no statistical difference in scores. Kuder-Richardson-20 formula was 0.65 and 0.67 for both questionnaires. Test-retest stability showed constant median scores of 9/13 and no statistical difference in scores between baseline and follow-up. Known groups comparison revealed that patients who had self-educated themselves about heart disease, or who were taking CVD medications, had significantly higher scores on the questionnaires.
Conclusion:
The two parallel forms of the HDFQ-RA have been shown to be equivalent measures of CVD knowledge and evidence supporting their reliability and validity is presented.
Practice Implications:
The HDFQ-RA is an appropriate tool for application in clinical and research settings, e.g., assessing novel educational interventions or tracking participants' progress on an education course.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease IV: Nursing Management
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease III: Medical Management
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
